Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gold

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Cancer Research|October 3, 2003
Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cellsHelene Lapillonne, Marina Konopleva, Twee Tsao, et al.
Pharmacological Research|July 1, 2004
PXR and the regulation of apoA1 and HDL-cholesterol in rodentsKenneth Bachmann, Hiral Patel, Zaid Batayneh, et al.
Rheumatology (Oxford, England)|August 15, 2019
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 yearsJanet Pope, Louis Bessette, Niall Jones, et al.
Epilepsy & Behavior : E&B|April 28, 2025
A pilot study of the feasibility and efficacy of an online group memory strategy training program for adults with epilepsyMary Lou Smith, Elizabeth N Kerr, Mary Pat McAndrews, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2007
Phase I participants' views of quality of life and trial participation burdensMarlene Zichi Cohen, Jacquelyn Slomka, Rebecca D Pentz, et al.
The Gerontologist|July 9, 2018
Evaluating Mobility in Advanced Dementia: A Scoping Review and Feasibility AnalysisKaren Van Ooteghem, Kristin Musselman, David Gold, et al.
The Journal of Biological Chemistry|October 27, 2004
Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signalingXiao-Feng Le, Amy Lammayot, David Gold, et al.
BMC Anesthesiology|November 10, 2021
Screening for subjective cognitive decline in the elderly via subjective cognitive complaints and informant-reported questionnaires: a systematic reviewSara Wasef, Isabelle Laksono, Paras Kapoor, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 12, 2019
Key factors for the assessment of mobility in advanced dementia: A consensus approachKaren Van Ooteghem, Kristin E Musselman, Avril Mansfield, et al.
Cancer Genetics and Cytogenetics|September 30, 2010
Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapseEunice S Wang, Sheila N J Sait, David Gold, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|October 3, 2003
Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cellsHelene Lapillonne, Marina Konopleva, Twee Tsao, et al.
Pharmacological Research|July 1, 2004
PXR and the regulation of apoA1 and HDL-cholesterol in rodentsKenneth Bachmann, Hiral Patel, Zaid Batayneh, et al.
Rheumatology (Oxford, England)|August 15, 2019
Experience with tofacitinib in Canada: patient characteristics and treatment patterns in rheumatoid arthritis over 3 yearsJanet Pope, Louis Bessette, Niall Jones, et al.
Epilepsy & Behavior : E&B|April 28, 2025
A pilot study of the feasibility and efficacy of an online group memory strategy training program for adults with epilepsyMary Lou Smith, Elizabeth N Kerr, Mary Pat McAndrews, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2007
Phase I participants' views of quality of life and trial participation burdensMarlene Zichi Cohen, Jacquelyn Slomka, Rebecca D Pentz, et al.
The Gerontologist|July 9, 2018
Evaluating Mobility in Advanced Dementia: A Scoping Review and Feasibility AnalysisKaren Van Ooteghem, Kristin Musselman, David Gold, et al.
The Journal of Biological Chemistry|October 27, 2004
Genes affecting the cell cycle, growth, maintenance, and drug sensitivity are preferentially regulated by anti-HER2 antibody through phosphatidylinositol 3-kinase-AKT signalingXiao-Feng Le, Amy Lammayot, David Gold, et al.
BMC Anesthesiology|November 10, 2021
Screening for subjective cognitive decline in the elderly via subjective cognitive complaints and informant-reported questionnaires: a systematic reviewSara Wasef, Isabelle Laksono, Paras Kapoor, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 12, 2019
Key factors for the assessment of mobility in advanced dementia: A consensus approachKaren Van Ooteghem, Kristin E Musselman, Avril Mansfield, et al.
Cancer Genetics and Cytogenetics|September 30, 2010
Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapseEunice S Wang, Sheila N J Sait, David Gold, et al.
Pageof 5